drugset
drugset / Trial / NCT04850261

Injection Free IVF

NCT04850261 ↗

Phase 2 Withdrawn Insel Gruppe AG, University Hospital Bern
RandomizedParallel-groupOpen-labelTreatment

Summary

Investigation of Natural Cycle In vitro Fertilisation (NC-IVF) treatment with ovulation induction with a nasal GnRH agonist instead of regular NC-IVF treatment with subcutaneous application of hCG with the objective of increasing treatment tolerability and reducing discomfort while being equally successful in terms of embryo transfer rates.

Timeline

Start
2021-05-01
Primary completion
2024-03-31
Completion
2024-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nafarelin Other / unclassified 200 ug Intranasal
Comparator human chorionic gonadotropin Protein / enzyme biologic 5000 iu Subcutaneous

Indications

infertility disorder